GE's Immelt and Sherin affirm SEC (US Securities and Exchange Commission) filings:
This article was originally published in Clinica
As the financial world struggles against a climate of uncertainty over corporate accounting irregularities - real or perceived - GE CEO Jeff Immelt and CFO Keith Sherin have signed and sworn statements with the US Securities and Exchange Commission certifying filings made so far this year. All US companies that are required to file periodic reports with the SEC must now have a personal certification by the firm's CEO and CFO that the reports are both accurate and complete. GE has acted some two weeks before the deadline. "Certifying our SEC filings underscores our unyielding commitment to integrity and to providing investors with accurate, relevant and understandable information about GE," said Mr Immelt.
You may also be interested in...
Sandoz announced more than a year ago that its GP2411 biosimilar denosumab candidate had entered the clinic. Management provided an update on its progress at the recent Virtual Meet Novartis Management Investor Event.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.